New and Upcoming Events

The webinar will show how it’s possible to gain a critical advantage in early-phase development by harnessing the power of Artificial Intelligence (AI).

Lonza will showcase the current capabilities, facility locations, timelines, and expertise in both Drug Substance (DS) and Drug Product (DP) development and manufacturing.

This webinar will provide a science-driven framework for extracellular vesicle (EV) characterization, focusing on the principles behind defining identity, purity, potency, and safety. We’ll discuss why early analytical planning is essential for establishi...

This webinar explores the strategic and operational benefits of integrating drug substance (DS) and drug product (DP) manufacturing within a unified CDMO framework.

This webinar will share new, real-world case studies that illustrate practical approaches to anticipating and overcoming these challenges. Examples will highlight how careful process design can mitigate risks, cross functional collaboration accelerates de...